Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP03-36 (Azelastine 0.15%) in Seasonal Allergic Rhinitis
NCT00824473Phase 3Completed
- Sponsor
- Meda
- Start
- Dec 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azelastine in seasonal allergic rhinitis (SAR), sponsored by Meda. Started Dec 2008; status: completed.
02
Drugs
azelastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00824473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824473.